FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $711,000 | -18.1% | 12,000 | +20.0% | 8.60% | -37.1% |
| Q2 2021 | $868,000 | +31.5% | 10,000 | +25.0% | 13.69% | +28.4% |
| Q1 2021 | $660,000 | +123.7% | 8,000 | +146.9% | 10.66% | +131.9% |
| Q4 2020 | $295,000 | -95.2% | 3,240 | -97.9% | 4.60% | -21.2% |
| Q3 2020 | $6,127,000 | +14.8% | 153,297 | -1.4% | 5.84% | -0.2% |
| Q2 2020 | $5,335,000 | +49.2% | 155,505 | -3.4% | 5.85% | +35.2% |
| Q1 2020 | $3,575,000 | +12.8% | 160,959 | -0.6% | 4.33% | +4.1% |
| Q4 2019 | $3,170,000 | +172.1% | 161,977 | +116.0% | 4.16% | +283.4% |
| Q3 2019 | $1,165,000 | – | 75,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |